The study cohort included 50 patients on semaglutide who were compared with 50 computer-matched patients (for age, gender, weight, BMI, ethnicity and diabetes duration) who were not on semaglutide or any other GLP-1 RA or weight loss medication. Here, GCG is linked to diabetes mellitus.